These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7040928)

  • 21. The pharmacologic alteration of renin release.
    Keeton TK; Campbell WB
    Pharmacol Rev; 1980 Jun; 32(2):81-227. PubMed ID: 7012850
    [No Abstract]   [Full Text] [Related]  

  • 22. Update on drug interactions involving antibiotics and antifungals.
    Wynn RL
    Gen Dent; 2004; 52(3):201-6. PubMed ID: 15206248
    [No Abstract]   [Full Text] [Related]  

  • 23. Accumulation of cardiac glycosides.
    Kuschinsky K
    Ger Med Mon; 1969 Apr; 14(4):198-202. PubMed ID: 4896950
    [No Abstract]   [Full Text] [Related]  

  • 24. Cardiac glycosides as novel inhibitors of human ether-a-go-go-related gene channel trafficking.
    Wang L; Wible BA; Wan X; Ficker E
    J Pharmacol Exp Ther; 2007 Feb; 320(2):525-34. PubMed ID: 17095614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac glycosides in cancer research and cancer therapy.
    Winnicka K; Bielawski K; Bielawska A
    Acta Pol Pharm; 2006; 63(2):109-15. PubMed ID: 17514873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiac glycosides stimulate Ca2+ increases and apoptosis in androgen-independent, metastatic human prostate adenocarcinoma cells.
    McConkey DJ; Lin Y; Nutt LK; Ozel HZ; Newman RA
    Cancer Res; 2000 Jul; 60(14):3807-12. PubMed ID: 10919654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Drug interactions between cardiac and circulatory drugs. Cardiac glycosides, anti-arrhythmia agents, sympathomimetics].
    Estler CJ
    Fortschr Med; 1981 Sep; 99(33):1285-95. PubMed ID: 7297975
    [No Abstract]   [Full Text] [Related]  

  • 28. [Toxic effects and pharmacokinetics of cardiac glycosides in mice with experimental radiation disease].
    Tilser I; Krupicková H; Kozák I
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1981; 24(1):123-41. PubMed ID: 6975978
    [No Abstract]   [Full Text] [Related]  

  • 29. Interactions between cardiac glycosides and sodium/potassium-ATPase: three-dimensional structure-activity relationship models for ligand binding to the E2-Pi form of the enzyme versus activity inhibition.
    Paula S; Tabet MR; Ball WJ
    Biochemistry; 2005 Jan; 44(2):498-510. PubMed ID: 15641774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of the alpha1beta1 isoform of the Na, K-ATPase by 8-methoxycoumestrol without positive inotropic effect in human myocardium--novel aspects of cardiac glycoside pharmacology.
    Potter T; Hauck C; Pôças ES; Diedrichs H; Adam C; Reuter H; Wittwer T; Wahlers T; da Silva AJ; Costa PR; Noël F; Müller-Ehmsen J
    J Cardiovasc Pharmacol; 2009 Jul; 54(1):10-5. PubMed ID: 19487957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A slide ruler and nomogram for calculations in cumulation kinetics of cardiac glycosides (author's transl)].
    Kratochvil L; Lustig M
    Basic Res Cardiol; 1976; 71(2):160-72. PubMed ID: 1267742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Drug interactions with oral anticoagulants and cardiac glycosides].
    Preiss R
    Z Arztl Fortbild (Jena); 1981 Jun; 75(11-12):546. PubMed ID: 7303751
    [No Abstract]   [Full Text] [Related]  

  • 33. [Unwanted drug interaction between anti-arrhythmic drugs and drugs used for heart failure].
    Jaźwińska-Tarnawska E; Orzechowska-Juzwenko K
    Pol Merkur Lekarski; 2000 Sep; 9(51):614-7. PubMed ID: 11126988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapy of chronic cardiac insufficiency with cardiac glycosides].
    Bonelli J
    Wien Med Wochenschr; 1982 Oct; 132(19):442-9. PubMed ID: 7179995
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical pharmacokinetics of cardiac glycosides in patients with renal dysfunction.
    Aronson JK
    Clin Pharmacokinet; 1983; 8(2):155-78. PubMed ID: 6342898
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of cardiac glycosides on the activity of serum cholinesterase].
    Meerzon RA
    Vrach Delo; 1969 Mar; 3():63-6. PubMed ID: 5369659
    [No Abstract]   [Full Text] [Related]  

  • 37. [Bronchoconstrictive effect of various cardiac glycosides].
    Grallert F; Rott Z
    Orv Hetil; 1980 Nov; 121(44):2690-2. PubMed ID: 7465211
    [No Abstract]   [Full Text] [Related]  

  • 38. Cardiac glycosides initiate Apo2L/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5.
    Frese S; Frese-Schaper M; Andres AC; Miescher D; Zumkehr B; Schmid RA
    Cancer Res; 2006 Jun; 66(11):5867-74. PubMed ID: 16740726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [On the mechanism of action of cardiac glycosides].
    WASER PG
    Schweiz Med Wochenschr; 1962 Jul; 92():819-28. PubMed ID: 14005099
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pharmacology of cardiac glycosides].
    CERLETTI A
    Verh Dtsch Ges Kreislaufforsch; 1960; 26():3-10. PubMed ID: 13691974
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.